Applying a Stability Budget to Cold Chain Biologics. Rebecca E. Gentile Merck & Co. Inc. June 2015

Similar documents
Stability Budget: Data the Superhero. we prove it.

PAR STERILE PRODUCTS. Affordable Products. Quality You Can Trust. MAY 2017 PRODUCT CATALOG

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER MANUFACTURERS, OUTSOURCING FACILITIES, OXYGEN SUPPLIERS AND WHOLESALERS/DISTRIBUTORS

Manage your Prescriptions Online Through the Express Scripts Pharmacy

PAR STERILE PRODUCTS. Affordable Products. Quality You Can Trust. FEBRUARY 2016 PRODUCT CATALOG

Technician Tutorial: Drug Expiration and Beyond-Use Dates

Vendor Application Wholesaler / Distributor Checklist

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

LFA Spot Checks of ACT Co-payment Mechanism First-Line Buyers: Terms of Reference

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

FOOD SAFETY RISK ANALYSIS

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics. Form No.

So You Want to Start Exporting. Craft Brewers Conference Denver, CO

Senate Bill No. 91 Senator Hardy

Impact of the AMP Final Rule on Class of Trade & Contracting

BAXTER RETURN GOODS / CREDIT POLICY FOR DISPOSABLES AND PARTS FOR US HOSPITAL PRODUCTS DIVISION

Notice of Rulemaking Hearing

Intel Corporation Connected Care Arizona Care Network

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

GALLERY MISSION STATEMENT

NEW BARDA CONTRACT FOR FREEZE-DRIED IMVAMUNE SEPTEMBER 2017

WELCOME. Your search for prescription benefit savings is now over.

FREQUENTLY ASKED QUESTIONS ABOUT THE CVS CAREMARK PRESCRIPTION DRUG PROGRAM

CUSTOMS ~ NOTES UNUSED DRAWBACK REQUIREMENTS UNDER NAFTA AND THE CUSTOMS MODERNIZATION ACT

Innovative Strategies for Managing the Rising Cost of Specialty Drugs

Good Practice Guidance 4: Expiry Dates for Medication Adapted from previous NHS Berkshire East guidance, Expiry Date Guidelines for Medication (2010).

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

Lakeland Pharmacy Please register as soon as possible to avoid late charges associated with rush service. Lakeland Pharmacy

Central Drugs Standard Control Organization

Keeping transportation on the move.

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

INFUSED ONCOLOGY PRODUCT RETURNS POLICY EARLY RETURNS PROGRAM

Frequently Asked Questions

Guide to The Notification System for Exempt Medicinal Products

Central Drugs Standard Control Organisation

Food Safety and Inspection Service, USDA 417.2

PRODUCT CONTAMINATION INSURANCE FOOD AND BEVERAGE APPLICATION

Central Drugs Standard Control Organization

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics

ORGANIGRAM HOLDINGS INC. ANNUAL INFORMATION FORM

Please read this document carefully before placing an order. By placing an order, you agree to the terms and conditions as set out below.

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

Strategic Capacity Planning for Biologics Under Demand and Supply Uncertainty

AbbVie US LLC. Standard Terms and Conditions Effective February 1, 2019

Client Risk Solutions Going beyond insurance. Risk solutions for the Manufacturing sector. Start

Labour Protection Requirements for the Protection of Employees from the Risk Caused by Vibration in the Work Environment

A REPORT BY THE NEW YORK STATE OFFICE OF THE STATE COMPTROLLER

Marine Cargo Questionnaire

Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier

Market and Liquidity Risk Examination Techniques. Federal Reserve System

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics

essential rewards THE AUTOSHIP ADVANTAGE

HEALTH, NUTRITION & LIFESTYLE APPLICATION

WHOLESALER DANGEROUS DRUGS & DANGEROUS DEVICES SELF- ASSESSMENT

SPD Prescription Drugs Plan

ADDENDUM #1. October 21, 2016

Temperature Sensitive Transportation Know the Risks. IMUA ANNUAL MEETING May 23, 2017 Russell Crooks

CH2 TERMS & CONDITIONS. Clifford Hallam Healthcare Pty Ltd (ACN )

IMPROVING TRANSPORTAION INDUSTRY RANDOM VIBRATION TESTS. John Van Baren Phillip Van Baren Vibration Research Corporation Jenison, MI

Terms and Conditions Information for Ordering Activities

HDMI Extender over Cat5e/6. User Manual. ALFAtron B20K. HDMI 2.0 Booster. All Rights Reserved

For personal use only

CLAIMS. ORTANT INFORMATION General TIPS on Claims

TRINITY UNIVERSITY THE PURCHASING CARD A GUIDE FOR USERS

General Terms and Conditions of Business. Lifetime Services

McKesson Medical Surgical Inc. Controlled Substance Customer Questionnaire and Declaration

PAUL DANIEL BOTTOMLEY, ATTORNEY FOR PLAINTIFF UNITED STATES OF AMERICA FOR THE DISTRICT OF 0F MONTANA BUTTE DIVISION UNITED STATES OF 0F AMERICA,

General Fund Total $761,594 $633,812 $645,863 $657,068. Minnesota Future Resources Fund ($1,022) ($1,055) ($1,001) ($949)

Property Handling Process

Drug Registration Requirements in Nigeria:

OPEN CARGO POLICY QUESTIONNAIRE & APPLICATION

STATEMENT OF LIMITED WARRANTY FIXTURES/ PRODUCTS

Chapter 8 Section 9.1

Stellar Linear High Bay

The PWCS Hazard Communication Program shall include provisions for the following:

of TGW Software Services GmbH for Lifetime Services 07/2014

Definitions.

Instructions for Use Reprocessed Laparoscope Accessories (Scissors, Dissectors, Graspers)

SOURCE CONTROL DRAWING OFFICIAL SPECIFICATION

CITY OF REDDING, CALIFORNIA COUNCIL POLICY

CODE OF CONDUCT: SOUTH AFRICAN ANIMAL HEALTH ASSOCIATION (SAAHA)

2) Estimated Gross Revenues for the next twelve (12) months or next fiscal year ($CDN): CANADA $ U.S. $ OTHER (please list countries): 11. Your Compan

Employment Practices. Warehouse Liability & Liability Coverage & Case Studies. Employment Practices

INDIAN INSTITUTE OF SCIENCE BENGALURU

Property Insurance. Endorsement. Additional Exclusions. Policy Period. Effective Date. Policy Number. Insured. Name of Company.

IMAP is equal to 68% of GTL MSRP. Example: $100 = MSRP per GTL $68 = IMAP. Global Tech LED IMAP File

RETURNS AND REFUNDS POLICY

HEALTH, NUTRITION & LIFESTYLE

Health and Safety Policy

Small-Cap Research. ADMA Biologics, Inc. (ADMA - NASDAQ) SUMMARY DATA ZACKS ESTIMATES

Benefits of Mutual Recognition Procedure (MRP) in East African Community (EAC) for regulators Tanzania experience. TANZANIA FOOD AND DRUGS AUTHORITY

GROWTH GEARED FOR GROWTH. Uni-Select TSX: UNS. Back to School Conference September 16, 2014 BE A PART OF IT.

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. Solve the problem.

LAW ON PRECURSORS I. GENERAL PROVISIONS Article 1 This Law shall regulate the system of monitoring and control of the manufacture and trade with

Prescription Medication Rider

Austin Warehouse & Distribution, Inc. Transportation, Warehouse & Storage Terms & Conditions

ANNEX 1 STRATEGIES BY NRRA TO DETECT ACTIONS, ACTIVITIES AND BEHAVIOURS THAT RESULT IN SSFFC MEDICAL PRODUCTS

This information reflects the position at the time of publication and you are advised to check the HSE website regularly for any updates.

ATTACHMENT V.F.2 DIRECT PROCUREMENT METHOD (DPM) BEST VALUE SCORE (BVS)

ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST SUBMISSIONS for DRUG REVIEWS

Transcription:

Applying a Stability Budget to Cold Chain Biologics Rebecca E. Gentile Merck & Co. Inc. June 2015

Overview Define Stability budget PDA Technical Report # 53 What is a stability budget Why set up a stability budget How to apply a stability budget How to establish a stability budget Case Study Regulatory Considerations Summary 2

PDA TR# 53: Guidance for Industry: Stability Testing to Support Distribution of New Drug Products The objective of TR# 53 is to describe the stability studies required to determine a stability budget for a drug product. Acknowledgements: Erik J. van Asselt, Rafik Bishara, Maryann Gribbin, Paul Harber, Ian G. King, Arminda O. Montero, Fabian S. de Paoli, Robert Seevers, David Ulrich 3

PDA TR# 53: Guidance for Industry: Stability Testing to Support Distribution of New Drug Products A stability budget considers long term, accelerated, and stress temperature exposure, as well as temp. cycling studies to determine the amount of time out of storage ( TOS ) that a drug product may experience without any significant risk to its quality. Other synonymous terms: Time out of Refrigeration TOR Time at Room Temperature TRT 4

Why Establish a Stability Budget? Temperature sensitive products may have limited time that they can be exposed to temperature outside label storage conditions and still meet quality attributes through expiry Definition of that exposure time, and distribution of parcels of time to product life cycle steps helps to ensure product won t be exposed to temperatures that exceed acceptable limits The Stability Budget ensures product will meet shelf life specifications given end to end TOS requirements Ensure product retains Quality (safety and efficacy) at time of patient administration 5

How to Apply a Stability Budget? The allowable TOS outside Long Term storage conditions must be budgeted among competing needs: Manufacturing Packaging Labeling Global transport End user Tracking and/or control of product exposure is essential at each step of the process and distribution chain Allowable TOS should account for both planned and unplanned excursions 6

PDA TR 53: Example Inputs to a Stability Budget Manufacturing Filling and Inspection Shipment Secondary packaging Shipment Warehouse Receive, store, Pack-out Final customer Handling and administration Shipment 3 rd party distributor/ wholesaler Receive, store, pack-out Shipment Excursion Bucket 7

How to Establish a Stability Budget? The stability budget may be established with data from Phase III Stability Studies (Formal Stability Studies) Requires LT and accelerated / stress studies, typically 3 lots per study, GMP studies Example stability studies to establish Stability Budget (5 C product) Long term: 5 C for 36 months Accelerated: 25 C for 6 months Shipping: 15 C for 3 months Extreme stress: 40 C 3 months Low Temp stress: 0-2 C or -20 C or lower for 30 days Cycling studies: -20 C for 5 days followed by 5C for 5 days x 4 cycles Sequential TOS study: thermal stress followed by LT storage A word about humidity 8

Temperature TOS Sequential Study Example TOS followed by long term storage condition 40 C 25 C 30 days 25 C 3 days 40 C 5 C 35 months 5 C Long term stability testing to confirm specifications are met through product expiry Time 9 36 months

Potency Statistical Model Example Requirement for separate release and end expiry specifications to account for LT and accelerated stability losses Manufacturing target Lower Release Limit Variability 25 C loss: 30 days 40 C loss: 3 days 5 C loss: 36 months LT storage Expiry Spec. Clinical effective dose 10 Time Expiry

Considerations for Biologics Products to Establish TOS Understand primary stability indicating parameters May be potency, may be other attribute, may be multiple attributes Effect of TOS exposure to aggregation and particulates is of high concern Be sure to measure as part of studies May need to consider combination stability studies: shock, vibration, and temperature stress combined Particularly important to support shipping at wider temperature ranges Consider early in product development address with formulation and image Carry over impact from drug substance Regulatory expectations: real life and simulated shipping studies 11

Stability Budget Example Example Product is: Liquid DP Minimal head space two primary stability attributes Do not freeze Stability Budget: 36 month expiry at 5 C (2-8 C) 20 days allowance at 15 C for shipping (0-15 C shipping range) 30 days allowance at 0-2 C for shipping and excursions 2 weeks allowance at 25 C (man/pack/label/end user) 5 days manufacturing 2 days labelling 1 day shipping packout and receipt 3 days end user 3 days remaining for excursions 12

Regulatory Considerations TOS Information may be included in product license: The 30 day exposure period at 23 27 C is comprised of: 7 days allowed for manufacturing and packaging operations, 3 days (72 hours) allowed for the end customer/administration purposes, Remaining 20 days allowed to support unplanned temperature excursions. End user TOS allowance may be added to label: Store refrigerated at 2 to 8 C (36 to 46 F). Do not freeze. Protect from light Product can be out of refrigeration (at temperatures at or below 25 C/77 F), for a total time of not more than 72 hours. 13

Summary Stability Budgets may be used as a way to control TOS for temperature sensitive products Maximum TOS supported by long term and accelerated / stress stability data Time allowances are divided among competing needs (i.e. manufacturing, transport, end-user) Design stability studies for temperature sensitive new products to support stability budget Stability Budgets ensure product quality through all phases of the sample life cycle 14